Veterinarians occasionally use compounded preparations to meet a specific patient’s medical need. The purpose of this brochure, created jointly by the Animal Health Institute (AHI), the American Veterinary Distributors Association (AVDA), and the American Veterinary Medical Association (AVMA), is to explain the Food and Drug Administration (FDA) requirements for compounding preparations for veterinary use and the distinction between drug products approved by the US FDA and compounded preparations.
Related Resources
Rhodococcus equi Disease Guidelines
Rhodococcus equi (R. equi) remains the most common cause of subacute or…
Position on the Use of Medroxyprogesterone Acetate in Competition Horses
Medroxyprogesterone acetate (MPA) is a synthetic progestin hormone administered to mares off-label…
Breeding Terminology
In providing written reports to interested parties, the AAEP encourages all equine…